| S.No |
Disease condition |
Mechanism proposed |
The animal model |
Refs |
| 1 |
MDR/XDR-Tb |
Adjunct therapy |
Autologous open label Phase-I safety trial |
[35] |
| 2 |
Bacterial diseases |
Immunosuppressive and anti-bacterial effects of MSCs |
Animal model |
[36] |
| 3 |
Broncho-pulmonary dysplasia |
Reparative and regeneration |
Animal model |
[37] |
|
